CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-31 | Garg Vipin K President and CEO | Grant or award | +11,289 | $1.46 | $16K | 326,206 |
| 2020-01-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +3,698 | $1.46 | $5K | 5,535 |
| 2020-01-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −2,015 | $1.77 | $4K | 314,917 |
| 2020-01-02 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Options (option to buy) | +61,400 | 61,400 | ||
| 2020-01-02 | Garg Vipin K President and CEO | Grant or award · Stock Options (option to buy) | +149,500 | 149,500 | ||
| 2020-01-02 | Harris Matthew Scott Chief Medical Officer | Grant or award · Stock Options (option to buy) | +61,400 | 61,400 | ||
| 2020-01-02 | Brown William Michael Chief Financial Officer | Grant or award · Stock Options (option to buy) | +61,400 | 61,400 | ||
| 2019-12-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −1,999 | $1.80 | $4K | 316,932 |
| 2019-11-30 | Garg Vipin K President and CEO | Shares withheld for taxes | −23,976 | $1.82 | $44K | 318,931 |
| 2019-09-09 | Harris Matthew Scott Chief Medical Officer | Grant or award · Stock Options (option to buy) | +107,000 | 107,000 | ||
| 2019-09-05 | Garg Vipin K President and CEO | Purchase | +20,000 | $2.10 | $42K | 342,907 |
| 2019-06-17 | Tasker Sybil Chief Medical Officer | Grant or award · Stock Options (option to buy) | +20,000 | 20,000 | ||
| 2019-06-10 | Brown William Michael Chief Financial Officer | Grant or award · Stock Options (option to buy) | +50,000 | 50,000 | ||
| 2019-03-26 | Tasker Sybil Chief Medical Officer | Grant or award · Stock Options (option to buy) | +38,000 | 38,000 | ||
| 2019-03-26 | Roberts M Scot Chief Scientific Officer | Grant or award · Stock Options (option to buy) | +38,000 | 38,000 | ||
| 2019-01-02 | Brown William Michael Acting Chief Financial Officer | Grant or award · Stock Options (option to buy) | +30,000 | 30,000 | ||
| 2019-01-02 | SAYARE MITCHEL Director | Grant or award · Stock Options (option to buy) | +30,000 | 30,000 | ||
| 2019-01-02 | Schafer Klaus Director | Grant or award · Stock Options (option to buy) | +20,000 | 20,000 | ||
| 2019-01-02 | Hodges Philip Director | Grant or award · Stock Options (option to buy) | +20,000 | 20,000 | ||
| 2019-01-02 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +20,000 | 20,000 |
Page 24 of 29 · 568 trades